Bellwether Trial Scheduled in Levaquin MDL Lawsuit
The fourth bellwether trial in the ongoing Levaquin multi district litigation case, which is taking place in Minnesota, has recently been scheduled. Presiding judge John R. Tunheim announced in a status conference held on the 4th of April, 2012, that the fourth bellwether trial dealing with Levaquin achilles tendon tears and other tendon rupture would take place on the 22nd of October, 2012. Three lawsuits have already seen trial, with two of them ending in verdicts in favor of the defendant, drug maker Johnson & Johnson. The third, however, which was the first to go to trial, ended with a $1.8 million decision in favor of the plaintiff. Other patients who have chosen to file a lawsuit after dealing with side effects are hoping to gain compensation for their injuries through their lawsuits.
Consolidation helps speed trial
More than 1,774 federal lawsuits have been consolidated in the Levaquin multi district litigation case that is currently taking place in the United States’ District Court for the District of Minnesota. These lawsuits have been consolidated in the interest of speeding up pretrial processes, discovery, and other aspects of the lengthy legal process. This will ultimately end up expediting and streamlining litigation so that decisions about individual cases can be reached more quickly.
Levaquin side effects of concern
Levaquin is the brand name version of the antibiotic known as Levofloxacin, manufactured by Johnson & Johnson. It is used in the treatment of a number of infections, including pneumonia, urinary tract infections, prostatitis, and other bacterial conditions. It is one of the most widely prescribed antibiotics in the country, and generates more than $1 billion annually for drug maker Johnson & Johnson. However, as it becomes more popular nationwide, the number of patients who report serious side effects resulting from Levaquin use grows. Thousands of lawsuits have already been filed by patients who have experienced Achilles tendon ruptures, rotator cuff tears, and other serious conditions that have been linked to the use of the antibiotic.